Cargando…

A real‐world experience of subcutaneous and transvenous implantable cardiac defibrillators—comparison with the PRAETORIAN study

BACKGROUND: PRAETORIAN is the first randomized controlled trial that demonstrated the noninferiority of subcutaneous ICD (S‐ICD) in comparison with transvenous ICD (TV‐ICD). We retrospectively reviewed electronic records of patients with ICD implanted over the past 6 years, with the primary objectiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khanra, Dibbendhu, Hamid, Abdul, Patel, Peysh, Tomson, John, Abdalla, Ahmed, Khan, Nasrin, Dowd, Rory, Chandan, Nakul, Osagie, Christopher, Jinadu, Tomilola, Velu, Selvakumar, Arya, Anita, Spencer, Charles, Barr, Craig, Petkar, Sanjiv
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977574/ https://www.ncbi.nlm.nih.gov/pubmed/35387142 http://dx.doi.org/10.1002/joa3.12687

Ejemplares similares

More Is Not Always More: A Timely Reminder Why Not to Use Too Much Hardware
por: Khanra, Dibbendhu, et al.
Publicado: (2022)

Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trial
por: Knops, Reinoud E, et al.
Publicado: (2022)

Incidence and Predictors of Implantable Cardioverter-defibrillator Therapies After Generator Replacement—A Pooled Analysis of 31,640 Patients’ Data
por: Khanra, Dibbendhu, et al.
Publicado: (2022)

Outcomes after transvenous defibrillator implantation in cardiac sarcoidosis: A systematic review
por: Taha, Ahmed, et al.
Publicado: (2022)

The Subcutaneous ICD: A Review of the UNTOUCHED and PRAETORIAN Trials
por: Karimianpour, Ahmadreza, et al.
Publicado: (2021)

Meta-analysis comparing outcomes of high-power short-duration and low-power long-duration radiofrequency ablation for atrial fibrillation
por: Khanra, Dibbendhu, et al.
Publicado: (2021)

Real-Life Inter-Rater Variability of the PRAETORIAN Score Values
por: Budrejko, Szymon, et al.
Publicado: (2022)

Electrocardiography Interpretation Proficiency Among Medical Doctors of Different Grades in the United Kingdom
por: Abdalla, Ahmed Ali, et al.
Publicado: (2022)

Comparative outcomes of subcutaneous and transvenous cardioverter-defibrillators
por: Liang, Jin-Jun, et al.
Publicado: (2019)

Improving use of proton pump inhibitors with dual antiplatelet therapy in patients admitted with acute coronary syndrome
por: Jinadu, Tomilola, et al.
Publicado: (2022)

Percutaneous Extraction of Transvenous Permanent Pacemaker/Defibrillator Leads
por: Paraskevaidis, Stylianos, et al.
Publicado: (2014)

Epicardial vs. transvenous implantable cardioverter defibrillators in children
por: Le Bos, Pierre Antoine, et al.
Publicado: (2023)

The “Defibrillation Testing, Why Not?” survey. Testing of subcutaneous and transvenous defibrillators in the Italian clinical practice()
por: Migliore, Federico, et al.
Publicado: (2022)

Left axillary active can positioning markedly reduces defibrillation threshold of a transvenous defibrillator failing to defibrillate at maximum output
por: Mitra, Raman L.
Publicado: (2018)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Forces Applied during Transvenous Implantable Cardioverter Defibrillator Lead Removal
por: Lennerz, Carsten, et al.
Publicado: (2014)

Transvenous Implantable Cardioverter-Defibrillator Lead Reliability: Implications for Postmarket Surveillance
por: Kramer, Daniel B, et al.
Publicado: (2015)

State‐of‐the‐art consensus on non‐transvenous implantable cardioverter‐defibrillator therapy
por: Schukro, Christoph, et al.
Publicado: (2020)

Comparison of quality-of-life measures in patients with transvenous and subcutaneous implantable cardioverter-defibrillators
por: Ferrick, Aileen M., et al.
Publicado: (2023)

Clinical course of hypertrophic cardiomyopathy patients implanted with a transvenous or subcutaneous defibrillator
por: Francia, Pietro, et al.
Publicado: (2023)

Impairment of Quality of Life in Patients with Implanted Subcutaneous Cardioverter Defibrillator (S-ICD) Compared to Implanted Transvenous Cardioverter Defibrillator Therapy
por: Thienel, Manuela, et al.
Publicado: (2022)

A sustained ventricular tachycardia overlooked by subcutaneous implantable cardioverter-defibrillator but recognized by co-implanted transvenous implantable cardioverter defibrillator
por: Goto, Kentaro, et al.
Publicado: (2020)

One-Year Follow-Up of Patients Undergoing Transvenous Extraction of Pacemaker and Defibrillator Leads
por: Kempa, Maciej, et al.
Publicado: (2015)

Risk Factors and Temporal Trends of Complications Associated With Transvenous Implantable Cardiac Defibrillator Leads
por: Koneru, Jayanthi N., et al.
Publicado: (2018)

Lead failure in transvenous implantable cardioverter defibrillator: a new opportunity for an effective management
por: Pignalberi, Carlo, et al.
Publicado: (2018)

Comparison of complications and shocks in paediatric and young transvenous and subcutaneous implantable cardioverter-defibrillator patients
por: Quast, A. B. E., et al.
Publicado: (2018)

Transvenous shock‐only implantable cardioverter defibrillator after an atrio‐pulmonary Fontan surgery
por: Toyohara, Keiko, et al.
Publicado: (2020)

Transvenous Implantable Cardioverter‐Defibrillator (ICD) Lead Performance: A Meta‐Analysis of Observational Studies
por: Providência, Rui, et al.
Publicado: (2015)

Clinical outcomes of subcutaneous vs. transvenous implantable defibrillator therapy in a polymorbid patient cohort
por: Kattih, Badder, et al.
Publicado: (2022)

Predictors of the need for supportive femoral approach during transvenous extraction of pacemaker and defibrillator leads in Japanese patients
por: Isawa, Tsuyoshi, et al.
Publicado: (2020)

Transvenous implantable cardioverter-defibrillator implantation in a patient with arrhythmogenic cardiomyopathy and massive right atrial thrombus
por: Hayashi, Hiroshi, et al.
Publicado: (2020)

Delayed perforation of the right ventricle by cardioverter-defibrillator lead – safe transvenous lead extraction by mechanical systems
por: Ząbek, Andrzej, et al.
Publicado: (2023)

Peripheral arterial disease in antiretroviral therapy naïve HIV infected patients – an experience from eastern India
por: Khanra, Dibbendhu, et al.
Publicado: (2014)

RETRACTED ARTICLE: Association of severity of coronary artery disease by SYNTAX score (SS) and lower extremity arterial disease by duplex ultrasound (DUS) study—an Indian perspective
por: Nandi, Saumen, et al.
Publicado: (2020)

Retraction Note: Association of severity of coronary artery disease by SYNTAX score (SS) and lower extremity arterial disease by duplex ultrasound (DUS) study—an Indian perspective
por: Nandi, Saumen, et al.
Publicado: (2020)

High-voltage impedance rise; mechanism and management in patients with transvenous implantable cardioverter-defibrillators: a case series
por: Monkhouse, Christopher, et al.
Publicado: (2019)

Sudden Cardiac Death in Children Affected by Cardiomyopathies: An Update on Risk Factors and Indications at Transvenous or Subcutaneous Implantable Defibrillators
por: Rella, Valeria, et al.
Publicado: (2020)

Efficacy and Safety of Transvenous Lead Extraction at the Time of Upgrade from Pacemakers to Cardioverter-Defibrillators and Cardiac Resynchronization Therapy
por: Stefańczyk, Paweł, et al.
Publicado: (2022)

Wild type transthyretin cardiac amyloidosis in a young individual: A case report
por: Ghosh, Shreya, et al.
Publicado: (2021)

Effectiveness and safety of transvenous extraction of single- versus dual-coil implantable cardioverter-defibrillator leads at single-center experience
por: Ząbek, Andrzej, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1dvd48296agd9m3h9cjvdqedam